nodes	percent_of_prediction	percent_of_DWPC	metapath
Mephentermine—ADRA1A—Adrenoceptors—ADRA2C—attention deficit hyperactivity disorder	0.122	0.141	CbGpPWpGaD
Mephentermine—ADRA1A—Adrenoceptors—ADRA2A—attention deficit hyperactivity disorder	0.0642	0.0742	CbGpPWpGaD
Mephentermine—ADRA1A—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0432	0.0499	CbGpPWpGaD
Mephentermine—ADRA1A—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0424	0.0489	CbGpPWpGaD
Mephentermine—ADRA1A—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0364	0.042	CbGpPWpGaD
Mephentermine—ADRA1A—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0356	0.0411	CbGpPWpGaD
Mephentermine—ADRA1A—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0257	0.0296	CbGpPWpGaD
Mephentermine—ADRA1A—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0247	0.0285	CbGpPWpGaD
Mephentermine—ADRA1A—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0239	0.0276	CbGpPWpGaD
Mephentermine—ADRA1A—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0231	0.0267	CbGpPWpGaD
Mephentermine—ADRA1A—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0227	0.0262	CbGpPWpGaD
Mephentermine—ADRA1A—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0224	0.0259	CbGpPWpGaD
Mephentermine—ADRA1A—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0216	0.0249	CbGpPWpGaD
Mephentermine—ADRA1A—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0209	0.0241	CbGpPWpGaD
Mephentermine—ADRA1A—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0201	0.0232	CbGpPWpGaD
Mephentermine—ADRA1A—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0194	0.0224	CbGpPWpGaD
Mephentermine—ADRA1A—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0191	0.0221	CbGpPWpGaD
Mephentermine—ADRA1A—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0189	0.0218	CbGpPWpGaD
Mephentermine—Tolazoline—ADRA2C—attention deficit hyperactivity disorder	0.0178	0.133	CrCbGaD
Mephentermine—ADRA1A—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0176	0.0203	CbGpPWpGaD
Mephentermine—ADRA1A—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.0146	0.0169	CbGpPWpGaD
Mephentermine—Pargyline—MAOA—attention deficit hyperactivity disorder	0.013	0.0965	CrCbGaD
Mephentermine—ADRA1A—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0123	0.0142	CbGpPWpGaD
Mephentermine—Methamphetamine—ADRA2C—attention deficit hyperactivity disorder	0.00987	0.0736	CrCbGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00835	0.00964	CbGpPWpGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00818	0.00944	CbGpPWpGaD
Mephentermine—ADRA1A—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00817	0.00944	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00812	0.00938	CbGpPWpGaD
Mephentermine—Tolazoline—ADRA2A—attention deficit hyperactivity disorder	0.00759	0.0566	CrCbGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00715	0.00826	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.007	0.00809	CbGpPWpGaD
Mephentermine—Phentermine—MAOA—attention deficit hyperactivity disorder	0.007	0.0521	CrCbGaD
Mephentermine—Pseudoephedrine—MAOA—attention deficit hyperactivity disorder	0.00663	0.0494	CrCbGaD
Mephentermine—Selegiline—MAOA—attention deficit hyperactivity disorder	0.00647	0.0482	CrCbGaD
Mephentermine—Phentermine—SLC6A3—attention deficit hyperactivity disorder	0.00603	0.0449	CrCbGaD
Mephentermine—Dextroamphetamine—SLC6A3—attention deficit hyperactivity disorder	0.00575	0.0429	CrCbGaD
Mephentermine—Pseudoephedrine—SLC6A3—attention deficit hyperactivity disorder	0.00572	0.0426	CrCbGaD
Mephentermine—Phenelzine—MAOA—attention deficit hyperactivity disorder	0.0057	0.0425	CrCbGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00567	0.00655	CbGpPWpGaD
Mephentermine—Pseudoephedrine—ADRA2A—attention deficit hyperactivity disorder	0.00561	0.0418	CrCbGaD
Mephentermine—ADRA1A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00544	0.00629	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00533	0.00616	CbGpPWpGaD
Mephentermine—Methamphetamine—MAOA—attention deficit hyperactivity disorder	0.00498	0.0371	CrCbGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00495	0.00572	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00486	0.00561	CbGpPWpGaD
Mephentermine—Amphetamine—SLC6A3—attention deficit hyperactivity disorder	0.00464	0.0346	CrCbGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00461	0.00532	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00459	0.0053	CbGpPWpGaD
Mephentermine—Phentermine—SLC6A4—attention deficit hyperactivity disorder	0.00451	0.0336	CrCbGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00446	0.00515	CbGpPWpGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00438	0.00506	CbGpPWpGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00433	0.005	CbGpPWpGaD
Mephentermine—Methamphetamine—SLC6A3—attention deficit hyperactivity disorder	0.0043	0.032	CrCbGaD
Mephentermine—Pseudoephedrine—SLC6A4—attention deficit hyperactivity disorder	0.00428	0.0319	CrCbGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00424	0.0049	CbGpPWpGaD
Mephentermine—Methamphetamine—ADRA2A—attention deficit hyperactivity disorder	0.00421	0.0314	CrCbGaD
Mephentermine—ADRA1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00417	0.00481	CbGpPWpGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00403	0.00466	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00395	0.00456	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00382	0.00441	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00376	0.00434	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00371	0.00428	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.0037	0.00427	CbGpPWpGaD
Mephentermine—ADRA1A—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00365	0.00422	CbGpPWpGaD
Mephentermine—Amphetamine—SLC6A4—attention deficit hyperactivity disorder	0.00347	0.0258	CrCbGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00346	0.00399	CbGpPWpGaD
Mephentermine—Amphetamine—DRD2—attention deficit hyperactivity disorder	0.00345	0.0257	CrCbGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00327	0.00378	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00323	0.00373	CbGpPWpGaD
Mephentermine—Methamphetamine—SLC6A4—attention deficit hyperactivity disorder	0.00321	0.0239	CrCbGaD
Mephentermine—ADRA1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00308	0.00355	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00301	0.00348	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.003	0.00347	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00291	0.00336	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00286	0.0033	CbGpPWpGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00283	0.00326	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00282	0.00326	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00279	0.00323	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00274	0.00316	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00263	0.00304	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00246	0.00284	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00242	0.0028	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00209	0.00241	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00192	0.00222	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.0019	0.00219	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00184	0.00213	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00183	0.00211	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.0017	0.00196	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00166	0.00192	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00165	0.00191	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00164	0.0019	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00162	0.00187	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00162	0.00187	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.0016	0.00184	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00159	0.00183	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00154	0.00178	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00149	0.00172	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00149	0.00172	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00147	0.0017	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00145	0.00167	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00135	0.00156	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00112	0.00129	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00104	0.0012	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00098	0.00113	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000946	0.00109	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000911	0.00105	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000882	0.00102	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000867	0.001	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000856	0.000989	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000798	0.000921	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000559	0.000645	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000296	0.000342	CbGpPWpGaD
